Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization

Autor: Giovanni Grazioso, Marco De Amici, Francesco Clementi, Sergio Fucile, Cristina Missale, Michele Zoli, Carlo Matera, Luca Pucci, Chiara Fiorentini, Clelia Dallanoce, Cecilia Gotti
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Agonist
alpha7 Nicotinic Acetylcholine Receptor
medicine.drug_class
Stereochemistry
Nicotinic Antagonists
α4β2 nAChRs
neuronal nicotinic acetylcholine receptors
nicotine addiction
Substrate Specificity
Structure-Activity Relationship
Dopamine receptor D2
binding affinity
Drug Discovery
medicine
Structure–activity relationship
Humans
Nicotinic Antagonist
Receptor
erk phosphorylation tests
Acetylcholine receptor
Pharmacology
Dose-Response Relationship
Drug

Molecular Structure
Chemistry
Receptors
Dopamine D2

Organic Chemistry
a4b2 nAChRs
Bifunctional ligands
Binding affinity
D2 receptors
Dopamine release
Electrophysiological assays
Erk phosphorylation tests
Neuronal nicotinic acetylcholine receptors
Nicotine addiction
Dopamine Agonists
HEK293 Cells
Drug Design
Drug Discovery3003 Pharmaceutical Science
General Medicine
Ligand (biochemistry)
Nicotinic agonist
D(2) receptors
electrophysiological assays
dopamine release
bifunctional ligands
Popis: We designed, prepared and tested a set of structural analogs 1–4 as new hybrid compounds by incorporating, through a common alkyl chain of variable length, the pharmacophoric elements of N-n-alkyl nicotinium salts (non-α7 nicotinic acetylcholine receptors antagonists) and of 7-hydroxy-2-(aminomethyl)chromanes (dopaminergic D2 receptor agonists). The target compounds, which were assayed in binding experiments and electrophysiological, functional and Erk1/2 activation tests, essentially combined the pharmacological profiles of their individual receptor ligands. Among the studied derivatives, hybrid 2, one of the shortest homologs, in addition to the antagonist nicotinic profile similar to the other three congeners, behaved as a high affinity ligand at the investigated heteromeric nAChRs and as a low efficacy agonist at D2Rs. These bifunctional derivatives represent novel pharmacological tools in the study of nicotine addiction.
Databáze: OpenAIRE